A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
Most cancer patients do not respond to immune checkpoint therapies and the availability of predictive biomarkers is limited. Here the authors propose a signature enriched for genes of TREM2hi macrophages and γδ T cells to predict response to immunotherapy.
Saved in:
Main Authors: | Donghai Xiong, Yian Wang, Ming You |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/f272e035b0804ec2a83b8daf7b11d346 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to: “Inconsistent prediction capability of ImmuneCells.Sig across different RNA-seq datasets”
by: Donghai Xiong, et al.
Published: (2021) -
Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
by: Susu Zheng, et al.
Published: (2021) -
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
by: Manuela Terranova-Barberio, et al.
Published: (2020) -
ASSOCIATION OF TREM-1 GENE POLYMORPHISMS WITH INFECTIVE ENDOCARDITIS
by: A. V. Ponasenko, et al.
Published: (2016) -
Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma
by: Shuo Hong, et al.
Published: (2021)